The table below provides a list of the drugs associated with non-serious adverse events identified in the scientific literature over the last week.
| Non-serious case reports | ||
| Drug name(s) | Adverse event(s) | No. of cases |
| Adalimumab | Dermatitis, Granuloma | 1 |
| Adalimumab | Eosinophilic gastroenteritis, Pregnancy | 1 |
| Adenosine | Dizziness | 1 |
| Afatinib | Acneiform eruptions, Paronychia, Skin eruptions | 1 |
| Afatinib | Hypotension | 1 |
| Alcohol | Haematoma | 1 |
| Allopurinol | Fixed drug eruptions | 1 |
| Aminolevulinic acid, HiPorfin | Hypertrophic scars, Pain | 1 |
| Amoxicillin | Exanthema, Pruritus | 1 |
| Apixaban | Gastrointestinal haemorrhage | 1 |
| Aripiprazole | Abdominal pain, Constipation, Diarrhoea, Fatigue, Mood disorders, Weight gain | 7 |
| Atezolizumab, Nivolumab | Palmoplantar pustulosis | 1 |
| Azathioprine, Mercaptopurine, Methotrexate, Vincristine | Nevi and melanomas, Skin eruptions | 1 |
| AZD 1222, Olmesartan medoxomil, PEG 400, Polysorbate 80, Tozinameran | Hypersensitivity, Skin disorders | 1 |
| Aztreonam, Carisoprodol, Cotrimoxazole, Hydroxycarbamide, Ibuprofen, Metronidazole, Naproxen, Valproate | Fixed drug eruptions | 13 |
| Bleomycin, Hydroquinone | Hyperpigmentation | 4 |
| Captopril | Vascular disorders | 1 |
| Cefalexin | Drug hypersensitivity | 1 |
| Citric acid/glucose/sodium citrate, Plasma | Hypocalcaemia | 1 |
| Clarithromycin, Ethambutol, Moxifloxacin | Appetite disorders, Nausea | 1 |
| COVID 19 vaccine | Lymphadenopathy | 5 |
| COVID 19 vaccine | Vitiligo | 1 |
| COVID 19 Vaccine Pfizer BioNTech | Thyroiditis | 1 |
| COVID 19 Vaccine Pfizer BioNTech | Vitiligo | 1 |
| Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine | Keratosis, Lichenoid eruptions | 1 |
| Dalteparin sodium | False test results | 1 |
| Dicycloplatin | Abnormal laboratory parameters, Anorexia, Asthenia, Back pain, Pain, Taste disorders | 1 |
| Dupilumab | Pustular psoriasis | 1 |
| Elasomeran | Exanthema, Injection site reactions, Skin disorders | 2 |
| Elasomeran, Tozinameran | Fatigue, Oedema, Pain | 4 |
| Elexacaftor/Ivacaftor/tezacaftor | Exanthema | 1 |
| Epinephrine | Angioedema, Lack of efficacy in life threatening diseases | 1 |
| Esomeprazole, Omeprazole | Hypomagnesaemia | 1 |
| Everolimus | Skin disorders | 1 |
| GSK 137173A, Hydroxychloroquine, Mycophenolate mofetil, Sulfasalazine, Ustekinumab | Diarrhoea, Fatigue, Gastrointestinal disorders | 2 |
| Hyaluronic acid | Injection site pain, Knee injuries, Oedema | 3 |
| Hyaluronidase | Skin disorders | 1 |
| Immune globulin | Exanthema | 1 |
| Immune globulin | Hypersensitivity | 3 |
| Insulin, Insulin aspart | Hyperglycaemia, Hypoglycaemia | 2 |
| Interferon alpha 2b, Sintilimab | Infections | 1 |
| Lactobacillus plantarum PS128 | Diarrhoea | 1 |
| Levetiracetam | Fixed drug eruptions | 1 |
| Levodopa/carbidopa | Gastrointestinal disorders, Hypotension, Orthostatic hypotension | 1 |
| Levosulpiride | Parkinsonian disorders | 1 |
| Liraglutide | Diarrhoea, Injection site reactions | 2 |
| Mesalazine, Sulfasalazine | Exanthema, Metabolic disorders, Taste disorders | 2 |
| Methylprednisolone | Sinus tachycardia, Skin disorders | 2 |
| Miglustat | Abdominal pain, Diarrhoea, Flatulence, Gastrointestinal disorders, Gastrointestinal motility disorders, Weight loss | 1 |
| Mometasone | Epistaxis | 2 |
| Naloxone | Lung disorders | 1 |
| Nivolumab | Arthralgia | 1 |
| Nivolumab | Nausea | 1 |
| Olanzapine | Oedema | 1 |
| Paclitaxel | Alopecia, Hyperkeratosis, Skin disorders | 1 |
| Paliperidone | Oedema | 1 |
| Panitumumab | Exanthema | 4 |
| Pneumococcal 13 valent CRM197 vaccine conjugate | Elevated liver enzymes | 1 |
| Pramipexole | Behavioural disorders | 3 |
| Prednisone | Abnormal laboratory parameters | 1 |
| Progesterone | Skin disorders | 1 |
| Propranolol | Hallucinations | 1 |
| Risperidone | Weight gain | 1 |
| Safinamide | Dyskinesias | 2 |
| Tofacitinib | Dizziness, Elevated creatinine levels, Elevated liver enzymes, Headache, Hypertriglyceridaemia, Lymphopenia, Uraemia | 4 |
| Tozinameran | Chilblains | 1 |
| Tozinameran | Exanthema, Lichenoid eruptions | 1 |
| Tozinameran | Purpura, Skin disorders, Skin pigmentation | 1 |
| Tozinameran | Thyroiditis | 2 |
| Trametinib | Acne | 1 |
Reference
- Non-serious case reports. Reactions Weekly 30 Mar 2022